Expand Energy Valuation
Is EXE * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EXE * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EXE * (MX$1699) is trading below our estimate of fair value (MX$2782.18)
Significantly Below Fair Value: EXE * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EXE *?
Other financial metrics that can be useful for relative valuation.
| What is EXE *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | n/a |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 6.8x |
| Enterprise Value/EBITDA | 13.5x |
| PEG Ratio | 0.9x |
Price to Earnings Ratio vs Peers
How does EXE *'s PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 29x | ||
VISTA A Vista Energy. de | 9.1x | 14.6% | Mex$95.8b |
EQT EQT | 77.3x | 49.8% | US$24.0b |
TOU Tourmaline Oil | 15.1x | 44.3% | CA$23.3b |
CTRA Coterra Energy | 14.5x | 22.5% | US$18.1b |
EXE * Expand Energy | 83.8x | 95.5% | Mex$21.3b |
Price-To-Earnings vs Peers: EXE * is expensive based on its Price-To-Earnings Ratio (83.8x) compared to the peer average (29x).
Price to Earnings Ratio vs Industry
How does EXE *'s PE Ratio compare vs other companies in the Global Oil and Gas Industry?
Price-To-Earnings vs Industry: EXE * is expensive based on its Price-To-Earnings Ratio (83.8x) compared to the Global Oil and Gas industry average (10.4x).
Price to Earnings Ratio vs Fair Ratio
What is EXE *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 83.8x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate EXE *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | n/a | Mex$2,000.16 0% | 12.0% | Mex$2,537.50 | Mex$1,645.41 | n/a | 19 |
| Nov ’25 | n/a | Mex$2,048.40 0% | 11.7% | Mex$2,595.40 | Mex$1,682.96 | n/a | 20 |
| Oct ’25 | n/a | Mex$1,879.21 0% | 11.8% | Mex$2,353.58 | Mex$1,529.83 | n/a | 19 |
| Sep ’25 | n/a | Mex$2,026.87 0% | 9.0% | Mex$2,317.46 | Mex$1,747.92 | n/a | 17 |
| Aug ’25 | n/a | Mex$1,968.28 0% | 7.8% | Mex$2,212.64 | Mex$1,743.86 | n/a | 17 |
| Jul ’25 | n/a | Mex$1,937.47 0% | 7.4% | Mex$2,154.16 | Mex$1,712.28 | n/a | 15 |
| Jun ’25 | n/a | Mex$1,788.27 0% | 7.1% | Mex$1,988.54 | Mex$1,580.64 | n/a | 16 |
| May ’25 | n/a | Mex$1,776.66 0% | 8.0% | Mex$1,991.08 | Mex$1,582.66 | n/a | 15 |
| Apr ’25 | n/a | Mex$1,671.92 0% | 10.3% | Mex$1,978.28 | Mex$1,429.68 | n/a | 14 |
| Mar ’25 | n/a | Mex$1,717.80 0% | 10.7% | Mex$2,034.69 | Mex$1,470.45 | n/a | 15 |
| Feb ’25 | n/a | Mex$1,747.09 0% | 11.1% | Mex$2,075.25 | Mex$1,543.57 | n/a | 15 |
| Jan ’25 | n/a | Mex$1,761.66 0% | 17.3% | Mex$2,426.47 | Mex$1,376.72 | n/a | 19 |
| Dec ’24 | n/a | Mex$1,831.40 0% | 14.6% | Mex$2,448.27 | Mex$1,528.00 | n/a | 19 |
| Nov ’24 | n/a | Mex$1,888.10 0% | 14.1% | Mex$2,511.53 | Mex$1,585.29 | n/a | 19 |
| Oct ’24 | n/a | Mex$1,896.79 0% | 14.8% | Mex$2,599.47 | Mex$1,573.83 | n/a | 19 |
| Sep ’24 | n/a | Mex$1,816.18 0% | 14.4% | Mex$2,461.15 | Mex$1,521.13 | n/a | 19 |
| Aug ’24 | n/a | Mex$1,791.81 0% | 15.2% | Mex$2,423.33 | Mex$1,430.44 | n/a | 19 |
| Jul ’24 | n/a | Mex$1,843.50 0% | 15.8% | Mex$2,465.21 | Mex$1,403.80 | n/a | 19 |
| Jun ’24 | n/a | Mex$1,889.30 0% | 16.7% | Mex$2,569.15 | Mex$1,462.99 | n/a | 19 |
| May ’24 | n/a | Mex$1,957.61 0% | 17.3% | Mex$2,696.43 | Mex$1,438.10 | n/a | 20 |
| Apr ’24 | n/a | Mex$2,123.63 0% | 16.1% | Mex$2,751.66 | Mex$1,504.24 | n/a | 17 |
| Mar ’24 | n/a | Mex$2,219.20 0% | 13.9% | Mex$2,805.95 | Mex$1,629.26 | n/a | 17 |
| Feb ’24 | Mex$1,639.47 | Mex$2,494.91 +52.2% | 12.5% | Mex$3,012.72 | Mex$2,033.59 | n/a | 16 |
| Jan ’24 | n/a | Mex$2,845.63 0% | 13.2% | Mex$3,595.22 | Mex$2,234.86 | n/a | 14 |
| Dec ’23 | n/a | Mex$2,839.42 0% | 13.5% | Mex$3,677.15 | Mex$2,322.41 | n/a | 14 |
| Nov ’23 | n/a | Mex$2,939.96 0% | 14.7% | Mex$3,820.37 | Mex$2,352.54 | n/a | 14 |
Analyst Forecast: Target price is less than 20% higher than the current share price.